We Apply Biomarker & Immune Monitoring Research to Assay Development for Pharmaceutical Clinical Trials & Diagnostic Testing

IBT has been a recognized leader in biomarker and immune monitoring research and testing for two decades. We conduct industry-leading immunology research and use this knowledge to develop novel clinical laboratory tests that monitor patients’ immune system responses to foreign substances such as chemicals, drugs, biopharmaceuticals, environmental contaminants and small-molecule compounds.

IBT offers both standard and customized contract testing and assay development services tailored specifically to the individual needs of our pharmaceutical and biotechnology clients.

  • Customized Immunological Testing
  • We offer customized immunological testing for pharmaceutical and biotechnology development. We characterize specialized cellular and humoral immune responses using the robust immunological technology collection for:

    • Allergen-specific IgE, IgG, IgG1, IgG4, IgA
    • Lymphocyte, Basophil, Eosinophil & Phagocyte Function Tests
    • Cytokines
    • Protein/DNA Arrays
    • Flow Cytometry & Cell Culture
    • Microbead Arrays
    • Epifluorescence
    • Custom ELISAs

    IBT offers an extensive array of assays to identify specific allergens and quantify serum immunoglobulin levels caused by those allergens. We provide highly accurate, rapid and specific IgE, IgG and IgA results for hundreds of allergens, including:

    • Grass, weed and tree pollens
    • Foods
    • Mold and yeasts
    • Insects and venoms
    • Mites and dust
    • Parasites and drugs
    • Animal epidermals and proteins
    • Occupational allergens

  • Cytokine Testing
  • Cytokines, the small molecules that are essential in the immune response to infectious agents, are often called “the messengers of the immune system.” They play a critical role in many normal and pathophysiological processes such as:

    • Allergic responses
    • Infectious and autoimmune diseases
    • Angiogenesis
    • Inflammation
    • Tumor growth & metastasis
    • Hematopoietic development

    IBT provides multiplexing array technologies that allow quick release of accurate, quantitative results for:

    • Interleukin 1 beta (IL-1ß)
    • Interleukin 2 (IL-2)
    • Interleukin 4 (IL-4)
    • Interleukin 5 (IL-5)
    • Interleukin 6 (IL-6)
    • Interleukin 8 (IL-8)
    • Interleukin 10 (IL-10)
    • Interleukin 12 (IL-12p70)
    • Interleukin 13 (IL-13)
    • Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
    • Interferon-gamma (IFN-γ)
    • Tumor Necrosis Factor alpha (TNF-α)
    • Other cytokines upon request

    IBT’s technical expertise allows clients to examine intracellular signaling events in distinct lymphocyte, basophil, eosinophil, and phagocytic subsets within complex cell populations. Flow cytometry and cell culture using activation-state antibodies with cell surface markers relates protein activity with cell function and clinical status.

E-mail this Page

Biomarkers, Immune Monitoring Research, Assay Development, Testing for Clinical Trials, Patient Care Diagnostics from

Your Name*

Your E-mail Address*

Recipient's E-mail Address*
(Separate up to 5 e-mail addresses with commas.)

Your Message

Personal Message

The e-mail address(es) that you supply to use this service will only be used to send the requested page.

* denotes required information

Please type the characters displayed above.